Wordt geladen...
A patient previously treated with ALK inhibitors for central nervous system lesions from ALK rearranged lung cancer: a case report
BACKGROUND: Patients with anaplastic lymphoma kinase (ALK)-rearranged non-small-cell lung cancer (NSCLC) are now preferentially treated with tyrosine kinase inhibitors (TKIs). However, patients treated with ALK inhibitors end up with acquired resistance. CASE PRESENTATION: We present a patient with...
Bewaard in:
| Gepubliceerd in: | Onco Targets Ther |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5066989/ https://ncbi.nlm.nih.gov/pubmed/27785052 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S112833 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|